Immediate Switching to Reduced Nicotine Cigarettes in a U.S.-Based Sample: The Impact on Cannabis Use and Related Variables at 20 Weeks

Author:

Meier Ellen1ORCID,Rubin Nathan2,Dermody Sarah S3,Tessier Katelyn M2,Hecht Stephen S4ORCID,Murphy Sharon4,Jensen Joni4,Donny Eric C5ORCID,al’Absi Mustafa6,Drobes David7,Koopmeiners Joe4,Denlinger-Apte Rachel5ORCID,Tidey Jennifer W8,Vandrey Ryan9,Thorne Cole1,Hatsukami Dorothy4ORCID

Affiliation:

1. Department of Psychology, University of Wisconsin—Stevens Point , Stevens Point, WI , USA

2. Biostatistics Core, Masonic Cancer Center, University of Minnesota , Minneapolis, MN , USA

3. School of Psychological Science, Oregon State University , Corvallis, OR , USA

4. University of Minnesota Masonic Cancer Center, 717 Delaware St. SE , Minneapolis, MN 55414 , USA

5. Department of Social Science and Health Policy, Wake Forest University School of Medicine , Winston-Salem, NC , USA

6. Department of Family Medicine and BioBehavioral Health, University of Minnesota Medical School , Duluth, MN , USA

7. Departments of Oncologic Sciences and Psychology, University of South Florida, Tampa , FL , USA

8. Department of Behavioral and Social Sciences, Brown University School of Public Health , Providence, RI , USA

9. Johns Hopkins University School of Medicine , Baltimore, MD 21224 , USA

Abstract

Abstract Introduction The FDA proposed rule-making to reduce nicotine in cigarettes to minimally addictive levels. Research suggests decreasing nicotine levels (i.e. very low nicotine content cigarettes [VLNCs]) produced greater quit attempts, reduced smoking, and reduced exposure to harmful constituents among smokers. The impact of long-term VLNC use among people who co-use cigarettes and cannabis on non-tobacco-specific toxicant and carcinogen exposure has not been investigated. Aims and Methods This study presents secondary analyses of a controlled clinical trial examining switching to VLNC (versus a normal nicotine cigarettes control group [NNCs]) between people who co-use cigarettes and cannabis (n = 174) versus smoked cigarettes (n = 555). Linear mixed-effects models compared changes in smoking behavior, and tobacco-specific (i.e. total nicotine equivalents [TNE], 4-[methylnitrosamino]-1-[3-pyridyl]-1-butanone [NNK; total NNAL]) and non-tobacco-specific (i.e. carbon monoxide (CO), 2-cyanoethylmercapturic acid [CEMA], phenanthrene tetraol [PheT]) toxicant and carcinogen exposure at week 20 (with random intercept for participants). Cannabis use was measured among co-use groups. Results CO was significantly lower only among the cigarette-only group assigned VLNCs (interaction: p = .015). Although both VLNC groups demonstrated decreased CEMA, greater decreases emerged among the cigarette-only group (interaction: p = .016). No significant interactions emerged for TNE, cigarettes per day (CPD), NNAL, and PheT (ps > .05); both VLNC groups decreased in TNE, CPD, and NNAL. Only the cigarette-only group assigned VLNCs demonstrated decreased PheT (p < .001). The VLNC co-use group showed increased cannabis use over time (p = .012; 0.5 more days per week by week 20). Conclusions Those who co-use cannabis and cigarettes may still be at risk for greater exposure to non-tobacco-specific toxicants and carcinogens compared to those who only smoke cigarettes. Implications The present study is the longest longitudinal, prospective comparison study of smoking behavior and exposure to harmful constituents among those who co-use cigarettes and cannabis versus cigarette-only after immediately switching to very low nicotine content cigarettes (VLNC). Those who co-use experienced similar reductions in CPD and tobacco-specific exposure, compared to those who only use cigarettes. However, co-use groups experienced smaller reductions in non-tobacco-specific toxicants and carcinogens compared to the cigarette-only group, potentially because of combustible cannabis use. Additionally, those who co-use and switched to VLNC may be susceptible to slight increases in cannabis use (approximately two more days per year).

Funder

National Institute on Drug Abuse

Food and Drug Administration

Center for Tobacco Products

Masonic Cancer Center, University of Minneso

National Center for Advancing Translational Sciences

National Institutes of Health

Publisher

Oxford University Press (OUP)

Subject

Public Health, Environmental and Occupational Health

Reference23 articles.

1. Randomized trial of reduced-nicotine standards for cigarettes;Donny;N Engl J Med.,2015

2. Evaluation of a reduced nicotine product standard: Moderating effects of and impact on cannabis use;Pacek;Drug Alcohol Depend.,2016

3. Cigarette smokers versus cousers of cannabis and cigarettes: exposure to toxicants;Meier;Nicotine Tob Res.,2020

4. Effect of immediate vs gradual reduction in nicotine content of cigarettes on biomarkers of smoke exposure: a Randomized Clinical Trial;Hatsukami;JAMA.,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3